Physician profile
Lisa Brinker
NPI 1972124642
$4,828.49
in general payments reported to CMS, 2019-2025
12 companies · $653 in 2025
The $653 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $45.56 · 2022: $3,820 · 2023: $143 · 2024: $167 · 2025: $653.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $963.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $962.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,235.36 | 2022 | |
| Pinnacle, INC | $564.65 | 2022-2023 | |
| Stryker Corporation | $258.14 | 2023-2025 | Mako, Aequalis Ascend Flex, Blueprint Patient Specific Instrumentation |
| Kerecis Limited | $235.46 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Kuros Biosciences USA, INC | $154.49 | 2025 | Magnetos |
| Pacira Pharmaceuticals Incorporated | $111.25 | 2025 | Iovera |
| Orthofix Medical, INC. | $101.72 | 2025 | Physio-Stim |
| Si-Bone, INC. | $45.56 | 2021 | |
| Novo Nordisk INC | $38.72 | 2022 | |
| Cerapedics INC. | $30.51 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Nevro Corp. | $27.46 | 2023 | Senza |
| Smith+Nephew, INC. | $25.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Brinker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.